Related Articles for PubMed (Select 15530168)

Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review.

Freedland ES.

Nutr Metab (Lond). 2004 Nov 5;1(1):12.

PMID: 15530168 [PubMed - as supplied by publisher]

Related Articles Free article in PMC

Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women?

Brochu M, Tchernof A, Turner AN, Ades PA, Poehlman ET.

Metabolism. 2003 May;52(5):599-604.

PMID: 12759890 [PubMed - indexed for MEDLINE]

Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.

Attallah H, Friedlander AL, Hoffman AR.

Growth Horm IGF Res. 2006 Jul;16 Suppl A:S62-7. Epub 2006 Apr 18. Review.

PMID: 16624603 [PubMed - indexed for MEDLINE]

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET.

J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5.

PMID: 11238480 [PubMed - indexed for MEDLINE]

The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ.

Int J Obes (Lond). 2006 Jun;30(6):877-83.

PMID: 16418758 [PubMed - indexed for MEDLINE]

Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.

Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF.

Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21. Review.

PMID: 12660870 [PubMed - indexed for MEDLINE]

Exercise in weight management of obesity.

Poirier P, Després JP.

Cardiol Clin. 2001 Aug;19(3):459-70. Review.

PMID: 11570117 [PubMed - indexed for MEDLINE]

Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.

Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, Volafova J, Bray GA.

Metabolism. 2001 Apr;50(4):425-35.

PMID: 11288037 [PubMed - indexed for MEDLINE]

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ.

Circulation. 2007 Jul 3;116(1):39-48. Epub 2007 Jun 18.

PMID: 17576866 [PubMed - indexed for MEDLINE]

10:

Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women.

Ross R, Fortier L, Hudson R.

Diabetes Care. 1996 Dec;19(12):1404-11.

PMID: 8941472 [PubMed - indexed for MEDLINE]

11:

The relationship of obesity to the metabolic syndrome.

Lebovitz HE.

Int J Clin Pract Suppl. 2003 Mar;(134):18-27. Review.

PMID: 12793594 [PubMed - indexed for MEDLINE]

12:

Visceral obesity and the metabolic syndrome: effects of weight loss.

Busetto L.

Nutr Metab Cardiovasc Dis. 2001 Jun;11(3):195-204. Review.

PMID: 11590996 [PubMed - indexed for MEDLINE]

13:

Metabolic obesity: the paradox between visceral and subcutaneous fat.

Hamdy O, Porramatikul S, Al-Ozairi E.

Curr Diabetes Rev. 2006 Nov;2(4):367-73. Review.

PMID: 18220642 [PubMed - indexed for MEDLINE]

14:

Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog.

Kim SP, Ellmerer M, Van Citters GW, Bergman RN.

Diabetes. 2003 Oct;52(10):2453-60.

PMID: 14514627 [PubMed - indexed for MEDLINE]

15:

Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance.

Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, Morioka K, Nakatani K, Yano Y, Adachi Y.

Diabetes Care. 2003 Aug;26(8):2341-4.

PMID: 12882859 [PubMed - indexed for MEDLINE]

16:

Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity.

Park HS, Lee K.

Diabet Med. 2005 Mar;22(3):266-72.

PMID: 15717873 [PubMed - indexed for MEDLINE]

17:

Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy?

Imbeault P, Lemieux S, Prud'homme D, Tremblay A, Nadeau A, Després JP, Mauriège P.

Metabolism. 1999 Mar;48(3):355-62.

PMID: 10094113 [PubMed - indexed for MEDLINE]

18:

Glucose uptake and insulin action in human adipose tissue--influence of BMI, anatomical depot and body fat distribution.

Stolic M, Russell A, Hutley L, Fielding G, Hay J, MacDonald G, Whitehead J, Prins J.

Int J Obes Relat Metab Disord. 2002 Jan;26(1):17-23.

PMID: 11791142 [PubMed - indexed for MEDLINE]

19:

The regulation of adipose tissue distribution in humans.

Björntorp P.

Int J Obes Relat Metab Disord. 1996 Apr;20(4):291-302. Review.

PMID: 8680455 [PubMed - indexed for MEDLINE]

20:

Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.

Masuzaki H, Flier JS.

Curr Drug Targets Immune Endocr Metabol Disord. 2003 Dec;3(4):255-62. Review.

PMID: 14683456 [PubMed - indexed for MEDLINE]

Recent Activity